LFG
GMAB icon

Larson Financial Group’s Genmab GMAB Stock Holding History

Larson Financial Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.19K Buy
189
+79
+72% +$2.1K ﹤0.01% 2757
2026
Q1 		$2.95K Sell
110
-112
-50% -$3.36K ﹤0.01% 2840
2025
Q4 		$6.84K Buy
222
+194
+693% +$6.05K ﹤0.01% 2326
2025
Q3 		$859 Buy
+28
New +$682 ﹤0.01% 2962
2023
Q4 		– Sell
-31
Closed -$1.09K – 1845
2023
Q3 		$1.09K Buy
+31
New +$1.18K ﹤0.01% 1474

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Larson Financial Group's GMAB Position: Q2 2026 in Review

Larson Financial Group increased its Genmab (GMAB) stake by 72% in Q2 2026, buying an estimated $2.1K and bringing the position to 189 shares worth $5.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2757.

Larson Financial Group first reported a position in GMAB in Q3 2023 and has held it in 5 quarters since. The position peaked at $6.84K in Q4 2025. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Larson Financial Group held 189 shares of Genmab worth $5.19K as of Q2 2026.
  • Larson Financial Group bought 79 Genmab shares in Q2 2026, an estimated $2.1K.
  • Genmab made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2757 holding.
  • Larson Financial Group first reported a position in Genmab in Q3 2023 and has held it in 5 quarters since.
  • Larson Financial Group's Genmab position peaked at $6.84K in Q4 2025.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.